Aurobindo Pharma is currently trading at Rs. 198.00, up by 1.45 points or 0.74% from its previous closing of Rs. 196.55 on the BSE. The scrip... ...
http://www.indian-commodity.com/equity/aurobindo-pharma-rises-on-receiving-usfda-nod-for-tamsulosin-hcl-capsules-and-pediatric.aspxTamsulosin Hydrochloride Capsules USP 0.4mg is the generic equivalent of Boehringer Ingelheim Pharmaceuticals Flomax Capsules, 0.4mg and is... ...
http://www.indiainfoline.com/Markets/News/Aurobindo-Pharma-gets-USFDA-nod-for-Tamsulosin-HCL-Capsules/5674114754Benign prostatic hyperplasia (BPH) medications are responsible for sexual side effects, dizziness, fatigue, and, according to a recent article in... ...
http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=588036